Published on 29/11/2025

Templates for COI/COC Logs and Chain Forms

Introduction to Chain-of-Identity and Chain-of-Custody

The biopharmaceutical industry demands immaculate compliance with Good Manufacturing Practices (cGMP) standards, particularly when it involves complex products such as Advanced Therapy Medicinal Products (ATMPs) and biologics. An essential component of this compliance is the assurance of Chain-of-Identity (COI) and Chain-of-Custody (COC) for materials throughout the manufacturing process.

COI ensures the identity of critical raw materials by tracking them from their source through to the final product, while COC establishes accountability for the materials’ custody and ensures that they have not been tampered with during transit. This article serves as a comprehensive tutorial on the creation and utilization of templates for COI and COC logs and chain forms instrumental in viral clearance validation, spiking studies, and the use of closed and single-use systems in compliance with regulatory practices set forth by the FDA, EMA, MHRA, and PIC/S.

Understanding Viral Clearance and Validation Procedures

Viral clearance validation is a fundamental process that enables pharmaceutical companies to demonstrate the efficacy of their purification processes against viral contaminants. Given the nature of biologics and ATMPs, determining the efficacy of viral clearance is paramount to ensuring product safety and regulatory compliance.

An essential aspect of viral clearance validation is the use of spiking studies, where viral representatives are intentionally introduced to the manufacturing process, allowing for the evaluation of the purification and filtration steps. By following an established protocol, organizations can facilitate the validation of their processes while maintaining the integrity of the product.

The regulatory expectations for viral clearance validation are articulated in various guidelines, notably ICH Q5A(R2), which outlines the overall strategy for ensuring viral safety. In conjunction with pertinent documentation of COI and COC, these guidelines inform the parameters for conducting effective validation processes.

Step 1: Establishing Templates for COI/COC Logs

The creation of effective COI/COC logs is critical in ensuring traceability throughout the manufacturing process. Templates serve as foundational tools for documenting all necessary information related to raw materials, production processes, and intermediates. Below are the key elements that should be included when developing your COI/COC log templates:

• Material Information: Include the name, type, and supplier of the material.
• Identity Check: Document the methods used to verify the identity of materials upon receipt and throughout processing.
• Transport Documentation: Include details from transport documents correlated with the material’s journey through the manufacturing process.
• Time and Date Stamps: Clearly record the time and date associated with every stage of identity checks and custody transfers.
• Signatures: Ensure that personnel involved in the custody and verification processes sign off on each entry.

By standardizing the COI/COC log, manufacturers can enhance their ability to maintain compliance with cGMP regulations and facilitate audits and inspections by regulatory bodies.

Step 2: Designing Chain Forms for Raw Material Tracking

The establishment of chain forms aids in efficiently tracking the raw materials through the production cycle. These forms assist in retaining detailed information regarding the origin and handling of materials while they remain in the closed systems or single-use systems often employed in modern biopharmaceutical manufacturing. Here are the significant components your chain forms should cover:

• Material Batch Number: Assign a unique batch number for clear identification.
• Source Verification: Document the location where the materials were sourced along with any certifications obtained.
• Handling History: Track who has handled the material and document any critical steps that could impact integrity.
• Expiration Dates: Include expiration or retest dates for materials that are subjected to validation timelines.
• Approval Sign-offs: Capture approval signatures at each checkpoint to ensure compliance.

The implementation of a robust chain form will contribute significantly to maintaining high standards of aseptic control, especially in accordance with Annex 1 guidelines, which detail the requirements for sterile manufacturing processes.

Step 3: Implementing Spiking Studies for Process Validation

Spiking studies are an essential component of demonstrating the effectiveness of viral clearance. These studies involve the deliberate introduction of viral contaminants into the manufacturing process at various points to assess the system’s contamination risk levels and the efficacy of the purification processes. Follow these steps to implement spiking studies effectively:

• Select Appropriate Viruses: Choose representative viral strains based on their relevance to the product being validated.
• Define Spiking Concentrations: Establish the concentration levels of the viruses introduced into the system to simulate realistic conditions.
• Document All Procedures: Ensure all aspects of the spiking study, including handling, processing methods, and analytical methods used for viral detection, are thoroughly documented.
• Validate Analytical Methods: Establish validated methods for detecting and quantifying the viral contaminants after processing.
• Review Results: Analyze the effectiveness of the purification process in eliminating the viral contaminants based on post-treatment measurements.

When spiking studies are conducted in conjunction with COI/COC logs, it builds a comprehensive validation strategy that addresses one of the key concerns for regulatory authorities—ensuring patient safety through effective product purification.

Step 4: Assuring Compliance Through Regular Audits and Reviews

To maintain compliance and identify areas for improvement, it is critical to establish a routine audit process for evaluating COI/COC logs, chain forms, and viral clearance validation documentation. These audits should focus on:

• Documentation Integrity: Confirm that all records are up-to-date, accurate, and compliant with regulatory guidelines.
• Staff Training: Ensure all personnel involved in COI/COC procedures and viral clearance validation are adequately trained and follow the established protocols.
• Process Efficiency: Evaluate the effectiveness of spiking studies and other validation efforts, identifying any bottlenecks or inefficiencies that could impede compliance.
• Regulatory Changes: Stay updated with changes in regulatory guidelines, particularly those issued by the EMA and MHRA, and ensure your documentation reflects the latest requirements.

Regular audits help cultivate a culture of quality and compliance within the organization, facilitating ongoing improvement and readiness for regulatory inspections.

Step 5: Emphasizing the Importance of Closed and Single-Use Systems in ATMP Manufacturing

The implementation of closed systems and single-use technologies has become a standard in modern biologics and ATMP manufacturing, providing significant benefits in reducing contamination risks and increasing flexibility. Below are critical pointers about the application of closed and single-use systems:

• Reduction of Contamination Risk: Closed systems prevent exposure to environmental factors, reducing the likelihood of product contamination.
• Operational Efficiency: Single-use technologies minimize the need for cleaning and validation of equipment, streamlining processes.
• Enhanced Compliance: Utilizing single-use systems aligns with cGMP requirements, simplifying regulatory compliance efforts.
• Cost-Effectiveness: These systems often reduce the need for extensive cleaning validation, thereby saving associated time and costs.

Furthermore, effective documentation practices concerning COI/COC and viral clearance validation become even more critical as production shifts toward these innovative systems. Keeping accurate records that reflect the seamless integration of these technologies into your operations ensures robust compliance.

Conclusion and Moving Forward with Compliance and Quality Assurance

Establishing and maintaining effective COI/COC logs and chain forms is paramount for compliance in the biopharmaceutical industry, especially within the dynamics of viral clearance validation. By adhering to defined processes and continuously ensuring that all components are accurately documented, organizations can uphold the standard of excellence required by pertinent regulatory bodies.

As the landscape of pharmaceutical manufacturing evolves, so too must the approaches towards validation practices, with a focused emphasis on building templates that align with the strategic goals of quality and safety. By fostering a culture of compliance, including the use of effective spiking studies and the integration of advanced manufacturing technologies, companies can fortify their positions in a market that increasingly demands accountability and transparency.

Ultimately, adherence to these principles enables organizations not only to meet regulatory expectations but also to ensure the safety and efficacy of the therapies provided to patients.